Captozyme

PRESS RELEASE: Captozyme Among Florida Companies to Watch

Captozyme, a Gainesville-based biotechnology company, is among 50 statewide companies expected to see significant growth over the next several years. Captozyme was selected from more than 500 nominees for Florida Companies to WatchSM, a statewide program managed by economic development group GrowFL, in association with the Edward Lowe Foundation.  

PRESS RELEASE: CAPTOZYME OPENS UP NEW HEADQUARTERS

GAINESVILLE, FL; April 26, 2017- Upon graduating from the University of Florida’s Innovation Hub, local biotechnology company, Captozyme Inc., recently acquired a newly constructed facility to house their new headquarters at 1622 NW 55th Place. The company plans to consolidate all operations there during the coming months, and is proud to be part of the developing biotechnology scene of Gainesville.

Captozyme Accepted to the NIH Commercialization Accelerator Program (CAP)

The NIH Commercialization Accelerator Program (CAP) is designed to help some of the agency’s most promising small life science and healthcare Phase II grantees develop their commercial businesses and transition their SBIR/STTR-funded technologies into the marketplace. Applicants are selected via a competitive process for a limited number of slots in the program.

See more information here: https://sbir.nih.gov/cap

Visit by Governor Rick Scott

Governor Rick Scott awarded Aaron and Helena Cowley the Young Entrepreneur Award for their work building Captozyme.  Aaron and Helena were among seven young business leaders to receive the award. 

About 40 people attended the event in the Innovation Hub in Gainesville; the Governor took a tour of the incubator with the entrepreneurs before presenting the award and addressing the media.